SAFETY AND EFFICACY OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN EARLY CLINICAL PRACTICE: A MULTICENTER ANALYSIS

Makoto Chuma  1     Haruki Uojima  2     Yoshitaka Arase  3     Nobuhiro Hattori  4     Taito Fukushima  5     Kazushi Numata  1    
1 Yokohama City University Medical Center, Yokohama, Japan
2 Kitasato University School of Medicine, Sagamihara, Japan
3 Tokai University School of Medicine, Isehara, Japan
4 St. Marianna University School of Medicine, Kawasaki, Japan
5 Kanagawa Cancer Center Hospital, Yokohama, Japan

Topic
Hepatobiliary, Histopathology

Session
Immune checkpoints in liver disease

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing